Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Identifying the Most Effective Hydatid Cyst Fluid Fraction for Anticancer Vaccination of 4T1 Breast Tumor-Bearing Mice Publisher



Daneshpour S1 ; Rostamirad S2 ; Kefayat A3 ; Mofid M4 ; Safavi A3 ; Darani H1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Parasitology and Mycology, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Clinical research development center, Najafabad branch, Islamic Azad university, Najafabad, Iran
  3. 3. Cancer Prevention Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
  4. 4. Department of Biochemistry, Bioinformatics Research Center, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran

Source: International Journal of Preventive Medicine Published:2019


Abstract

Background: The hydatid cyst fluid antigens have high homology with cancer cell antigens and also exhibit considerable immunogenicity. Therefore, their utilization for cancer immunization can cause an effective antitumor immune response. However, the main challenge is identifying the most effective antigens for this purpose. Methods: Hydatid cyst fluid fractions including the glycolipid fraction, glycoprotein fraction, 78 kDa fraction, and antigen B fraction were prepared. Then, the BALB/c mice were immunized against different antigens and, subsequently, 4T1 cells were subcutaneously implanted. The tumors' growth, metastasis, and tumor-bearing mice survival were assessed in different immunized groups. In addition, IL-2, IL-4, IFN-γ, and TNF-α serum levels were estimated to evaluate the immune system response. Results: BALB/c mice immunization against the complete hydatid cyst fluid antigens exhibited more significant inhibition of the tumors' growth and metastasis and increase of tumor-bearing mice survival in comparison with its derived fractions. However, the 78 kDa fraction exhibited the best results according to the same factors in comparison with all the prepared fractions. Conclusions: The 78 kDa fraction of the hydatid cyst fluid was the most effective fraction of hydatid cyst fluid for immunization against 4T1 breast tumors. © 2019 Wolters Kluwer Medknow Publications. All rights reserved.
Related Docs
View other Related Docs
1. Effect of Two Hydatid Cyst Antigens on the Growth of Melanoma Cancer in C57/Black Mice, Journal of Parasitic Diseases (2016)
2. Monoclonal Antibodies Production Against a 40Kda Band of Hydatid Cyst Fluid, Recent Patents on Biotechnology (2018)
3. Effect of Hydatid Cyst Antigens on Inhibition of Melanoma Cancer Growth in Mouse Model, Cellular and Molecular Biology (2018)
4. Anti-Cancer Immunoprotective Effects of Immunization With Hydatid Cyst Wall Antigens in a Non-Immunogenic and Metastatic Triple-Negative Murine Mammary Carcinoma Model, International Immunopharmacology (2021)
5. Inhibition of Mouse Colon Cancer Growth Following Immunotherapy With a Fraction of Hydatid Cyst Fluid, Experimental Parasitology (2023)
6. Effect of Alive Protoscoleces of Hydatid Cyst on the Growth of Melanoma Cells in Mouse Model, Journal of Isfahan Medical School (2014)
7. Parasites As Potential Targets for Cancer Immunotherapy, Journal of Cancer Research and Clinical Oncology (2023)
8. Investigating the Reaction of Antisera Against Hydatid Cyst Antigens With the Surface of Breast Cancer (4T1), Melanoma (B16f10), and Normal Spleen Cells Using Flow Cytometry Technique, Journal of Isfahan Medical School (2018)
Experts (# of related papers)
View all Related Experts
Hossein Yousofi Darani (22)
Zahra Ghayour Najafabadi (5)
Other Related Docs
9. Effect of Hydatid Cyst Antigens Polyspecific Antisera on Breast Cancer Cells (4T1) Growth in Cell Culture Medium, International Journal of Environmental Health Engineering (2022)
10. Effect of Hydatid Cyst Fluid Antigens on Induction of Apoptosis on Breast Cancer Cells, Advanced Biomedical Research (2019)
11. Anti-Toxoplasma Gondii Antibodies Attach to Mouse Cancer Cell Lines But Not Normal Mouse Lymphocytes, Biomedical Reports (2019)
12. Antibody Response to Glycan Antigens of Hydatid Cyst Fluid, Laminated Layer and Protoscolex of Echinococcus Granulosus, Medical Journal of the Islamic Republic of Iran (2017)
13. Parasites and Immunotherapy: With or Against?, Journal of Parasitic Diseases (2016)
14. Efficacy of Co-Immunization With the Dna and Peptide Vaccines Containing Sycp1 and Acrbp Epitopes in a Murine Triple-Negative Breast Cancer Model, Human Vaccines and Immunotherapeutics (2021)
15. Low Titer of Antibody Against Toxoplasma Gondii May Be Related to Resistant to Cancer, Journal of Cancer Research and Therapeutics (2015)
16. Immunotherapy a New Hope for Cancer Treatment: A Review, Pakistan Journal of Biological Sciences (2018)
17. Evaluating the Gene Expression Level of Il-12 in the Fibrous Layer of Hepatic Hydatid Cysts Isolated From Slaughtered Animals, Comparative Clinical Pathology (2015)
18. Mutual Action of Anticancer and Antiparasitic Drugs: Are There Any Shared Targets?, Future Oncology (2014)
19. Parasites and Cancers: Parasite Antigens As Possible Targets for Cancer Immunotherapy, Future Oncology (2012)
20. In Silico Analysis of Synaptonemal Complex Protein 1 (Sycp1) and Acrosin Binding Protein (Acrbp) Antigens to Design Novel Multiepitope Peptide Cancer Vaccine Against Breast Cancer, International Journal of Peptide Research and Therapeutics (2019)
21. Investigating the Effect of Cgrp78 Vaccine Against Different Cancer Cells and Its Role in Reducing Melanoma Metastasis, Research in Pharmaceutical Sciences (2024)
22. Changes in Immune Profile Affect Disease Progression in Hepatocellular Carcinoma, International Journal of Immunopathology and Pharmacology (2022)
23. Immunohistochemical Observation of Local Inflammatory Cell Infiltration in the Host-Tissue Reaction Site of Human Hydatid Cysts, Journal of Helminthology (2019)
24. Cancer Vaccines As a Targeted Immunotherapy Approach for Breast Cancer: An Update of Clinical Evidence, Expert Review of Vaccines (2022)
25. Apoptosis Genes Expression in Bovine Lymphocytes in Response to Fertile and Infertile Hydatid Cyst Fluid, Journal of Veterinary Research (2019)
26. Bioinformatics Design of a Peptide Vaccine Containing Sarcoma Antigen Ny-Sar-35 Epitopes Against Breast Cancer and Evaluation of Its Immunological Function in Balb/C Mouse Model, PLoS ONE (2024)
27. Immunoprotective Effect of an in Silico Designed Multiepitope Cancer Vaccine With Boris Cancer-Testis Antigen Target in a Murine Mammary Carcinoma Model, Scientific Reports (2021)
28. The Protective and Therapeutic Effect of Dna Vaccine Derived From Immunogenic Components of Boris Antigen on Colon Cancer in Balb/C Mice, Journal of Isfahan Medical School (2021)
29. Spirulina Extract Enriched for Braun-Type Lipoprotein (Immulina®) for Inhibition of 4T1 Breast Tumors' Growth and Metastasis, Phytotherapy Research (2020)
30. In Vitro Selective Depletion of Cd4+Cd25+ Regulatory T-Cells From Pbmc Using Anti-Tac-Sap, Journal of Immunotoxicology (2012)
31. Enhanced in Vivo Anti-Tumor Efficacy of Whole Tumor Lysate in Combination With Whole Tumor Cell-Specific Polyclonal Antibody, Research in Pharmaceutical Sciences (2023)
32. Echhinococcus Granulosus Lnfection in Mice Following Lmmunization With Protoscoleces Antigens, Journal of Isfahan Medical School (2009)
33. Immunological Diagnosis of Human Hydatid Cyst Using Western Immunoblotting Technique, Journal of Research in Medical Sciences (2016)
34. A Survey on Apoptosis and Hydatid Cyst Infertility, Journal of Isfahan Medical School (2021)
35. Exploring the Cancer-Testis Antigen Boris to Design a Novel Multi-Epitope Vaccine Against Breast Cancer Based on Immunoinformatics Approaches, Journal of Biomolecular Structure and Dynamics (2022)
36. The Evaluation of Tlyp-1-Bound Mda-7/Il-24 Killing Activity on a Liver Tumor Cell Line, Cancer Biotherapy and Radiopharmaceuticals (2021)
37. In Silico Designing Breast Cancer Peptide Vaccine for Binding to Mhc Class I and Ii: A Molecular Docking Study, Computational Biology and Chemistry (2016)
38. Stimulation of Camel Polyclonal Antibody Against Human T Cell Immunoglobulin and Mucin 3, Iranian Journal of Biotechnology (2017)
39. Immunization Using Male Germ Cells and Gametes As Rich Sources of Cancer/Testis Antigens for Inhibition of 4T1 Breast Tumors' Growth and Metastasis in Balb/C Mice, International Immunopharmacology (2019)
40. Introduction of a New Recombinant Vaccine Based on Grp78 for Breast Cancer Immunotherapy and Evaluation in a Mouse Model, BioImpacts (2023)
41. Human Anti-Toxoplasma Antibodies Attach Strongly to Breast Cancer Cells, International Journal of Cancer Management (2023)
42. Bioinformatic Designing for Producing Vaccine Peptide of Human Vascular Endothelial Growth Factor (Vegf-A), and Evaluation of Polyclonal Antibodies in Mice, Journal of Isfahan Medical School (2016)
43. In Silico Analysis of Transmembrane Protein 31 (Tmem31)Antigen to Design Novel Multiepitope Peptide and Dna Cancer Vaccines Against Melanoma, Molecular Immunology (2019)
44. Th1/Th2-Type Cytokine Profile in C57 Black Mice Inoculated With Live Echinococcus Granulosus Protoscolices, Journal of Infection and Public Health (2018)
45. Apoptosis As a Potential Target to Arrest and Survival of Hydatid Cyst, Advanced Biomedical Research (2023)
46. The Molecular Perspective on the Melanoma and Genome Engineering of T-Cells in Targeting Therapy, Environmental Research (2023)